Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sameer Khanijo

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Chest|March 9, 2020
Acute Respiratory Failure Associated With VapingCraig Fryman, Becky Lou, Andrew G Weber, et al.
Journal of Hematology|October 9, 2018
Chylothorax in Patients with Chronic Lymphocytic Leukemia: A Case SeriesDaniel Sammartino, Sameer Khanijo, Seth Koenig, et al.
Cureus|July 18, 2024
Teratoma to Angiosarcoma: A Metamorphosis in the MediastinumSudeep Acharya, Ngowari Pokima, Ekrem Yetiskul, et al.
Journal of Community Health|December 18, 2013
Community healthcare delivery post-Hurricane Sandy: lessons from a mobile health unitCynthia Lien, John Raimo, Jessica Abramowitz, et al.
BMC Health Services Research|May 22, 2023
Application of the RE-AIM framework to evaluate the implementation of telehealth pulmonary rehabilitation in a randomized controlled trial among African-American and Hispanic patients with advanced stage Chronic Obstructive Pulmonary DiseaseJennifer Polo, Melissa J Basile, Meng Zhang, et al.
Cureus|September 16, 2022
Attenuation of Human Growth Hormone-Induced Rash With Graded Dose ChallengeJake Mann, Dennis Caruana, Evelyn Luo, et al.
JAMA Internal Medicine|October 7, 2021
Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical TrialAlex C Spyropoulos, Mark Goldin, Dimitrios Giannis, et al.
Thrombosis and Haemostasis|April 6, 2021
Treatment-Dose LMWH versus Prophylactic/Intermediate Dose Heparins in High-Risk COVID-19 Inpatients: Rationale and Design of the HEP-COVID TrialMark Goldin, Dimitrios Giannis, Wassim Diab, et al.
Cureus|December 7, 2022
Randomized Open Investigation Determining Steroid Dose in Severe COVID-19: The ROIDS-Dose Clinical TrialCarlos X Rabascall, Becky X Lou, Sean Dhar, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Chest|March 9, 2020
Acute Respiratory Failure Associated With VapingCraig Fryman, Becky Lou, Andrew G Weber, et al.
Journal of Hematology|October 9, 2018
Chylothorax in Patients with Chronic Lymphocytic Leukemia: A Case SeriesDaniel Sammartino, Sameer Khanijo, Seth Koenig, et al.
Cureus|July 18, 2024
Teratoma to Angiosarcoma: A Metamorphosis in the MediastinumSudeep Acharya, Ngowari Pokima, Ekrem Yetiskul, et al.
Journal of Community Health|December 18, 2013
Community healthcare delivery post-Hurricane Sandy: lessons from a mobile health unitCynthia Lien, John Raimo, Jessica Abramowitz, et al.
BMC Health Services Research|May 22, 2023
Application of the RE-AIM framework to evaluate the implementation of telehealth pulmonary rehabilitation in a randomized controlled trial among African-American and Hispanic patients with advanced stage Chronic Obstructive Pulmonary DiseaseJennifer Polo, Melissa J Basile, Meng Zhang, et al.
Cureus|September 16, 2022
Attenuation of Human Growth Hormone-Induced Rash With Graded Dose ChallengeJake Mann, Dennis Caruana, Evelyn Luo, et al.
JAMA Internal Medicine|October 7, 2021
Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical TrialAlex C Spyropoulos, Mark Goldin, Dimitrios Giannis, et al.
Thrombosis and Haemostasis|April 6, 2021
Treatment-Dose LMWH versus Prophylactic/Intermediate Dose Heparins in High-Risk COVID-19 Inpatients: Rationale and Design of the HEP-COVID TrialMark Goldin, Dimitrios Giannis, Wassim Diab, et al.
Cureus|December 7, 2022
Randomized Open Investigation Determining Steroid Dose in Severe COVID-19: The ROIDS-Dose Clinical TrialCarlos X Rabascall, Becky X Lou, Sean Dhar, et al.
Pageof 2